FAST vs SER · P/E 43, rev $7.55B vs rev $56.0K
Fastenal Company (FAST) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. SER currently screens at market cap $29.7M.
Not investment advice. Open the FAST and SER stock pages for the full models.
Not investment advice.